ControversyFibroid treatmentA wealth of choiceUterine artery embolization versus myomectomy: a multicenter comparative study
Key Words
Cited by (0)
S.C.G. has received funding from and is a consultant for Boston Scientific Corporation. This study was funded by grants from Boston Scientific Corporation.
The UAE vs. Myomectomy Study Group: Paul R. Dong, M.D., and Michael S. Broder, M.D., David Geffen School of Medicine at University of California-Los Angeles; Richard W. Tureck, M.D., Hospital of the University of Pennsylvania; John C. Lipman, M.D., Radiology Associates of Atlanta; Gary P. Siskin, M.D., Albany Medical Center; John L. Nosher, M.D., and Gloria A. Bachmann, M.D., Robert Wood Johnson Medical Center; Merle H. Barth, M.D., and Amy E. Young, M.D., The Methodist Hospital; Mahmood K. Razavi, M.D., and Bertha H. Chen, M.D., Stanford University Medical Center; Theodore P. Chambers, M.D., and Glenna R. Anderson, M.D., Fairfax Hospital; Robert L. Worthington-Kirsch, M.D., Roxborough Memorial Hospital; Lynda T. Thomas, M.D., Chestnut Hill Hospital; Richard A. Reed, M.D., and Shafeeq S. Shamsid-Deen, M.D., Huntington Memorial Hospital; Keith M. Sterling, M.D., and Barry S. Rothman, M.D., INOVA Alexandria Hospital; Gerald A. Niedzwiecki, M.D., Mease Hospital; Elizabeth A. Stewart, M.D., Brigham and Women’s Hospital; Linda D. Bradley, M.D., Cleveland Clinic Foundation; Timothy R. Yeko, M.D., The Reproductive Medicine Group.
The UAE vs. Myomectomy Study Group Clinical Events Committee: James B. Spies, M.D., Georgetown University Medical Center; Douglas M. Coldwell, Ph.D., M.D., University of Mississippi; Keith B. Isaacson, M.D., MIGS Center at Newton Wellesley Hospital.
The UAE vs. Myomectomy Study Group Core Laboratory: Reena C. Jha, M.D., Georgetown University Medical Center; Susan M. Ascher, M.D., Georgetown University Medical Center.